Study of Stress Hyperglycemia as an Indicator of Diabetes Mellitus

Stress Hyperglycemia as an Indicator for Future Diabetes Mellitus: A Prospective Cohort Study

Status

Terminated

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02068989

Enrollment

Registered

2014-02-21

Start date

2013-02-28

Completion date

2015-03-31

Last updated

2016-09-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus Type 2, Stress Hyperglycemia

Brief summary

We hypothesize that stress hyperglycemia is an indicator that a patient will develop type 2 diabetes mellitus in the future. Subjects who are not diabetic are enrolled and blood glucose readings reviewed during their intensive care unit stay. All subjects are consented and have a HbA1C level drawn to determine if they have diabetes mellitus or not. They are then followed up in 1 year and the HbA1C repeated to determine if they have developed diabetes mellitus over the course.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* All patients admitted to the intensive care unit at the Yale New Haven Hospital St. Raphael Campus and Norwalk Hospital

Exclusion criteria

* Patients with prior history of diabetes mellitus * Elevated admission HbA1c (≥6.5%) * Age \>80 years * Metastatic disease with expected life expectancy of less than 12 months * Pregnancy or a woman who plans to become pregnant

Design outcomes

Primary

Measure	Time frame
Percentage of Subjects with an HbA1c greater than or equal to 6.5%	1 year

Countries

United States

Outcome results